2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
133
Brain Neoplasms
129
Prostatic Neoplasms
108
Neoplasm Metastasis
88
Lung Neoplasms
74
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
69
Breast Neoplasms
50
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
34
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
17
Small Cell Lung Carcinoma
15
Sarcoma
13
Kidney Neoplasms
13
Glioma
12
Urinary Bladder Neoplasms
10
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Central Nervous System Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Radiation Injuries
6
Prostate Cancer Metastatic
6
Neuroma, Acoustic
6
Interventions
lanreotide
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Temozolomide
1
Surveys and Questionnaires
1
Solutions
1
Radiosurgery
1
Observation
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Complementary Therapies
1
Biological Therapy
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Growth Hormone-Secreting Pituitary Adenoma
×
Radiosurgery
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled